Our Top 5 Microcap Stocks
Microcap stocks tend to be an under-researched area… Which increases the odds of discovering attractive investment opportunities.

Just like these 5 which appear to be in an excellent position to see a surge in share price.
>>> See All 5 Here
pixel
Alistair Macdonald net worth and biography

Alistair Macdonald Biography and Net Worth

He joined our Company in 2002 and has served in various senior leadership roles during that time. Prior to his current role, Mr. Macdonald most recently served as our President from January 2015 to October 2016 and as Chief Operating Officer from January 2013 to October 2016. He also served as President, Clinical Development Services from March 2012 to January 2013, Executive Vice President of our Global Oncology Unit from February 2011 to March 2012, Executive Vice President, Strategic Development from October 2009 to February 2011, and Senior Vice President, Biometrics from May 2002 to September 2009.

Mr. Macdonald currently serves on the Board of Directors of the Association of Clinical Research Organizations and Medicines Discovery Catapult, an independent, not-for-profit company, funded by an agency of the UK government. Mr. Macdonald received his Master of Science in Environmental Diagnostics from Cranfield University.

What is Alistair Macdonald's net worth?

The estimated net worth of Alistair Macdonald is at least $7.00 million as of April 9th, 2021. Mr. Macdonald owns 200,470 shares of Syneos Health stock worth more than $7,000,412 as of December 5th. This net worth approximation does not reflect any other assets that Mr. Macdonald may own. Additionally, Mr. Macdonald receives an annual salary of $1,250,000.00 as CEO at Syneos Health. Learn More about Alistair Macdonald's net worth.

How old is Alistair Macdonald?

Mr. Macdonald is currently 52 years old. There are 6 older executives and no younger executives at Syneos Health. Learn More on Alistair Macdonald's age.

What is Alistair Macdonald's salary?

As the CEO of Syneos Health, Inc., Mr. Macdonald earned a total compensation package of $8,364,510.00 in 2021. Mr. Macdonald earned a salary of $1,114,884.00, stock awards of $7,111,804.00, and other compensation of $137,822.00. Learn More on Alistair Macdonald's salary.

How do I contact Alistair Macdonald?

The corporate mailing address for Mr. Macdonald and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected] Learn More on Alistair Macdonald's contact information.

Has Alistair Macdonald been buying or selling shares of Syneos Health?

Alistair Macdonald has not been actively trading shares of Syneos Health over the course of the past ninety days. Most recently, Alistair Macdonald sold 35,553 shares of the business's stock in a transaction on Tuesday, August 3rd. The shares were sold at an average price of $87.96, for a transaction totalling $3,127,241.88. Learn More on Alistair Macdonald's trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 12 times. They sold a total of 29,562 shares worth more than $2,341,080.56. The most recent insider tranaction occured on July, 28th when COO Michael Lee Brooks sold 1,002 shares worth more than $78,156.00. Insiders at Syneos Health own 0.3 % of the company. Learn More about insider trades at Syneos Health.

Information on this page was last updated on 7/28/2022.

Alistair Macdonald Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/3/2021Sell35,553$87.96$3,127,241.88View SEC Filing Icon  
4/9/2021Sell14,039$80.00$1,123,120.00200,470View SEC Filing Icon  
4/1/2021Sell17,398$77.61$1,350,258.78231,907View SEC Filing Icon  
2/2/2021Sell64,497$75.71$4,883,067.87
12/22/2020Sell1,200$70.02$84,024.00245,487View SEC Filing Icon  
8/3/2020Sell10,289$65.07$669,505.23
7/14/2020Sell5,173$58.68$303,551.64264,809View SEC Filing Icon  
2/13/2019Sell8,143$53.00$431,579.00View SEC Filing Icon  
2/5/2019Sell6,697$53.04$355,208.88View SEC Filing Icon  
9/18/2017Sell2,348$54.60$128,200.8099,453View SEC Filing Icon  
8/17/2017Sell8,828$55.65$491,278.20110,629View SEC Filing Icon  
7/3/2017Sell10,555$58.38$616,200.9083,935View SEC Filing Icon  
5/1/2017Sell9,467$45.00$426,015.0083,935View SEC Filing Icon  
3/3/2017Sell8,828$45.00$397,260.0083,296View SEC Filing Icon  
1/20/2017Sell1,375$50.50$69,437.5052,854View SEC Filing Icon  
1/5/2017Sell14,840$52.19$774,499.6069,069View SEC Filing Icon  
8/17/2016Sell8,828$43.80$386,666.4063,057View SEC Filing Icon  
7/11/2016Sell9,468$40.19$380,518.9228,144View SEC Filing Icon  
12/31/2015Sell159,599$47.46$7,574,568.548,699View SEC Filing Icon  
12/7/2015Sell42,959$44.63$1,917,260.1755,681View SEC Filing Icon  
9/28/2015Sell44,522$39.93$1,777,763.4655,681View SEC Filing Icon  
See Full Table

Alistair Macdonald Buying and Selling Activity at Syneos Health

This chart shows Alistair Macdonald's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $34.92
Low: $34.49
High: $35.75

50 Day Range

MA: $41.89
Low: $25.70
High: $51.45

2 Week Range

Now: $34.92
Low: $22.89
High: $104.17

Volume

2,356,900 shs

Average Volume

817,729 shs

Market Capitalization

$3.59 billion

P/E Ratio

12.70

Dividend Yield

N/A

Beta

1.69
Our Top 5 Microcap Stocks
Microcap stocks tend to be an under-researched area… Which increases the odds of discovering attractive investment opportunities.

Just like these 5 which appear to be in an excellent position to see a surge in share price.
>>> See All 5 Here
pixel